Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
West Cobar Metals Unveils Promising Resource Estimate at Bulla Park Project
Metal & Mining Stocks

West Cobar Metals Unveils Promising Resource Estimate at Bulla Park Project

Highlights,Inferred resource of 19.7Mt defined with copper, antimony, and silver.,Exploration target set at 30–50Mt with higher copper equivalent grades.,Metallurgical testing shows strong recovery rates and clean concentrates.,The mining sector continues...

Emyria Expands Access to Psychedelic-Assisted Therapy with New Centre Launch in Perth
Healthcare Stocks

Emyria Expands Access to Psychedelic-Assisted Therapy with New Centre Launch in Perth

Highlights,Emyria opens second mental health centre in Perth,Fully funded patient treatments begin,Plans aligned for national expansion,Emyria Ltd (ASX:EMD) is making significant strides in Australia’s mental health sector with the expansion of its psyche...

Ample Transfers Receives In-Principle Approval from MAS to Expand Regulated Payment Services in Singapore
PRNews

Ample Transfers Receives In-Principle Approval from MAS to Expand Regulated Payment Services in Singapore

Ample Transfers plans to broaden digital payment capabilities following in-principle approval from the Monetary Authority of Singapore. SINGAPORE, April 14, 2025 /PRNewswire/ -- Ample Transfer...

  • April 14, 2025 11:30 AM AEST
  • Cision
BetMakers Rides Momentum with Strong Q3, Eyes Global Expansion and Tech Upgrades
Consumer Stocks

BetMakers Rides Momentum with Strong Q3, Eyes Global Expansion and Tech Upgrades

Highlights,Q3 FY25 revenue climbs with rising margins,Global reach expands across 30+ countries,Cost base trimmed, paving way for profitability,BetMakers Technology Group (ASX:BET) has released its Q3 FY25 financial results, showcasing solid operational a...

Droneshield (ASX:DRO) Gains Momentum with Major Asia-Pacific Defense Contracts
Technology Stocks

Droneshield (ASX:DRO) Gains Momentum with Major Asia-Pacific Defense Contracts

Highlights,Shares surge after $30M in new contracts,Five agreements secured with military-linked reseller,Short interest trends reflect shifting market sentiment,In the rapidly evolving defense technology space, Droneshield (ASX:DRO) continues to attract ...

Turning the Tide on Toxic Waste: How (ASX:EGL) Is Shaping Australia's PFAS Clean-Up
Industrial Stocks

Turning the Tide on Toxic Waste: How (ASX:EGL) Is Shaping Australia's PFAS Clean-Up

Highlights,EPA approval boosts confidence in PFAS treatment plant,Foam fractionation sets new benchmark in waste tech,Strategic public-private collaboration shows strong promise,As the world sharpens its focus on environmental sustainability, the need for...

Muddy Waters warns US tariffs risks economic self-harm without broader strategy
Stock Market

Muddy Waters warns US tariffs risks economic self-harm without broader strategy

This article first appeared in Investing.com

Insiders Signal Confidence: Multiple Leaders Invest in SomnoMed Shares
Healthcare Stocks

Insiders Signal Confidence: Multiple Leaders Invest in SomnoMed Shares

Highlights,Multiple insiders recently,acquired,shares in,SomnoMed,Largest insider purchase valued at AU$295k,Insider ownership stands at 7% of the company,Insider activity often offers unique insights into a company’s internal confidence. In the case of S...

Whyalla Steelworks Faces $180 Million Roadblock Amid Revival Efforts
Metal & Mining Stocks

Whyalla Steelworks Faces $180 Million Roadblock Amid Revival Efforts

Highlights,Whyalla,steelworks requires $180 million in urgent repairs,Over 200 critical maintenance issues,identified,Ownership history cited as a key factor behind infrastructure decline,The future of the Whyalla steelworks hangs in the balance as a rece...

Neuren Pharmaceuticals Surges as FDA Greenlights Key Phase 3 Trial
Healthcare Stocks

Neuren Pharmaceuticals Surges as FDA Greenlights Key Phase 3 Trial

Highlights,Neuren,gains FDA nod for crucial Phase 3 trial,Trial targets rare neurological disorder in children,Shares jump over 18% in early ASX trading,Shares of,Neuren Pharmaceuticals (ASX:NEU),rallied strongly on Monday, outperforming the broader ASX 2...

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.